API
< Back to all clusters
[HEALTH] · Brazil · 28 sources

started · updated

Anvisa prohibits unregistered weight-loss pens and hormone implants

The Brazilian National Health Surveillance Agency (Anvisa) has issued several resolutions to seize and prohibit the sale of unregistered medical products. A major focus of the enforcement is on weight-loss medications, specifically products containing tirzepatide and retatrutide, being sold illegally through various websites such as Zyntra Shop, ZPHC Store, and Peptídeos do Brasil.

Anvisa highlighted that retatrutide is an experimental substance that currently lacks sanitary registration in any country worldwide. The agency also prohibited products from Liberty Pharma due to unknown origins and items from Cris Barden Naturopatia Ltda. for making unauthorized therapeutic claims, such as anti-inflammatory and antimicrobial properties.

Additionally, Anvisa suspended the sale and use of all sterile hormone implants manufactured by MC Legacy Lab due to serious irregularities, including the distribution of products before sterility and endotoxin tests were completed, and the sale of implants without individual medical prescriptions. The agency also ordered the seizure of a specific batch of tirzepatide from Farmausa Pharmaceutical Ltda. following a failure to comply with previous disposal orders.

Entities

Anvisa · Brazil · Cris Barden Naturopatia Ltda. · Farmausa Pharmaceutical Ltda. · Liberty Pharma · MC Legacy Lab Produtos Médicos e Farmacêuticos

Claims

What the coverage asserts, and how many sources carry each claim.

Sources